ACM
TELA icon

Archon Capital Management’s TELA Bio TELA Stock Holding History

Archon Capital Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-150,000
Closed -$453K – 55
2024
Q4 		$453K Buy
+150,000
New +$422K 0.44% 35

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Archon Capital Management's TELA Position: Q1 2025 in Review

Archon Capital Management sold out of TELA Bio (TELA) in Q1 2025, closing a stake of 150,000 shares — an estimated $453K sold.

Archon Capital Management first reported a position in TELA in Q4 2024 and held it in 1 quarter. The position peaked at $453K in Q4 2024. 50 funds tracked by Wall St. Rank hold TELA as of Q1 2025.

  • Archon Capital Management reported no remaining TELA Bio position as of Q1 2025 after selling out during the quarter.
  • Archon Capital Management sold 150,000 TELA Bio shares in Q1 2025, an estimated $453K.
  • Archon Capital Management first reported a position in TELA Bio in Q4 2024 and held it in 1 quarter.
  • Archon Capital Management's TELA Bio position peaked at $453K in Q4 2024.
  • 50 funds tracked by Wall St. Rank held TELA Bio as of Q1 2025.

Based on Archon Capital Management's 13F filing for Q1 2025, filed 14 May 2025.